Ignite Creation Date:
2025-12-24 @ 5:03 PM
Ignite Modification Date:
2025-12-28 @ 9:14 PM
Study NCT ID:
NCT07014150
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-06-10
First Post:
2025-05-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Therapy of iIparomlimab and Tuvonralimab Combined With Lenvatinib for Hepatocellular Carcinoma
Sponsor:
Peking Union Medical College Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-06-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-05-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-05-31
Completion Date Type:
ESTIMATED
First Submit Date:
2025-05-29
First Submit QC Date:
None
Study First Post Date:
2025-06-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-08
Last Update Post Date:
2025-06-10
Last Update Post Date Type:
ACTUAL